Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Crescent Biopharma, Inc.
AI Executive Summary
AI-powered analysis of 8-K filing content
Crescent Biopharma held its Annual Meeting of Shareholders on June 2, 2026, with 27.6 million ordinary shares represented. The meeting addressed key corporate governance matters and strategic decisions that will influence the company's future direction.
Key Takeaways
Annual shareholder meeting held on June 2, 2026 with strong attendance of 27,571,935 ordinary shares
Record date for voting eligibility was April 7, 2026
2 more takeaways